The recently published proposal for the 9th edition of the TNM staging system (TNM9) for HPV-related oropharyngeal squamous cell carcinoma (HPV + OPC), primarily based on imaging-detected extranodal extension (iENE), introduces significant revisions improving risk stratification [1]. However, gene expression profiling (GEP) has emerged as a robust approach to cancer classification, outperforming anatomically based staging systems [2,3]. In a previous study (BD2Decide) [4] we externally validated a 3-cluster transcriptomic model (3Cl-GEP) that stratified patients with HPVpositive OPSCC into biologically distinct prognostic groups, independently of TNM8 [3,5]. Here, we assessed the performance of this molecular model relative to TNM9 [1] within the same cohort.

Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancer / Cavalieri, S., Brakenhoff, R.H., Leemans, C.R., Hoebers, F., Scheckenbach, K., Hoffmann, T.K., Mattavelli, D., Poli, T., Orlandi, E., Licitra, L., De Cecco, L.. - In: ORAL ONCOLOGY. - ISSN 1368-8375. - 170:(2025). [10.1016/j.oraloncology.2025.107685]

Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancer

Poli T.;
2025-01-01

Abstract

The recently published proposal for the 9th edition of the TNM staging system (TNM9) for HPV-related oropharyngeal squamous cell carcinoma (HPV + OPC), primarily based on imaging-detected extranodal extension (iENE), introduces significant revisions improving risk stratification [1]. However, gene expression profiling (GEP) has emerged as a robust approach to cancer classification, outperforming anatomically based staging systems [2,3]. In a previous study (BD2Decide) [4] we externally validated a 3-cluster transcriptomic model (3Cl-GEP) that stratified patients with HPVpositive OPSCC into biologically distinct prognostic groups, independently of TNM8 [3,5]. Here, we assessed the performance of this molecular model relative to TNM9 [1] within the same cohort.
2025
Transcriptomic based prognostic model versus TNM 9th edition in HPV-positive oropharyngeal cancer / Cavalieri, S., Brakenhoff, R.H., Leemans, C.R., Hoebers, F., Scheckenbach, K., Hoffmann, T.K., Mattavelli, D., Poli, T., Orlandi, E., Licitra, L., De Cecco, L.. - In: ORAL ONCOLOGY. - ISSN 1368-8375. - 170:(2025). [10.1016/j.oraloncology.2025.107685]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/3074760
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact